TDX/TDXFLX CANNABINOIDS REAGENT 9671-60

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2006-11-08 for TDX/TDXFLX CANNABINOIDS REAGENT 9671-60 manufactured by Abbott Health Products, Inc..

Event Text Entries

[15556934] The customer stated that while pipetting x-systems cannabinoids controls from the positive control vial, she pushed so hard on the pipette (attempting to tighten a loose pipette tip to the pipette barrel) that the pipette tip went through the bottom of the control vial and punctured her finger causing it to bleed. The customer was not wearing gloves at the time of the event. The customer washed and rinsed the wound for 10 minutes. The abbott customer technical advocate (cta) discussed and referenced the precautions listed in the product's package insert. The customer consulted with a physician and went to the emergency department where she was administered a tetanus shot. There is no further impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[15991353] Also reference 510(k)#: k874646 (delta-9 reformulation calibrators and controls). Why not code (h3): (a review of the complaint documentation identified that the event was caused by human error and did not involve the device nor was caused by a failure of the device). A review of the complaint documentation identified that the event occurred when the operator pushed too hard when pipetting a control sample, which punctured the bottom of the control bottle and in turn punctured the operator's finger. The event was not caused by a malufunction of the device or a product performance issue. The event was caused by user error. This event is addressed in the tdx/tdxflx cannabinoids package insert (34-3966/r7), warnings and precautions for users section and in the x-systems cannabinoids control package insert (34-39621/r10), precautions section, where documentation emphasizes that samples and reagents should be handled with appropriate biosafety practices. The investgation demonstrated that the tdxflx cannabinoids assay is performing within its intended use, label claims and specifications. No deficiency related to the performance of the device was identified. This is a final report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2623532-2006-00003
MDR Report Key777850
Report Source06
Date Received2006-11-08
Date of Report2006-10-31
Date of Event2006-10-31
Date Mfgr Received2006-10-31
Date Added to Maude2006-11-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactDR DAVID BARCH, D-09Y6, AP6C-2
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 600646092
Manufacturer CountryUS
Manufacturer Postal600646092
Manufacturer Phone8479379328
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTDX/TDXFLX CANNABINOIDS REAGENT
Generic NameCANNABINOID TEST SYSTEM
Product CodeLDJ
Date Received2006-11-08
Model NumberNA
Catalog Number9671-60
Lot NumberUNK
ID NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrN
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key765623
ManufacturerABBOTT HEALTH PRODUCTS, INC.
Manufacturer AddressKM 58.0, CARRETERA 2 CRUCE DAVILA BARCELONETA PR 00617 US
Baseline Brand NameTDX/TDXFLX CANNABINOIDS REAGENT
Baseline Generic NameCANNABINOID TEST SYSTEM
Baseline Model NoNA
Baseline Catalog No9671-60
Baseline IDNA


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2006-11-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.